Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Make sure you check these pages frequently, or sign up to our newsletter! To sign up for ESMO newsletters, create a myESMO account here and select the newsletters you’d like to receive.
Immune checkpoint inhibitor treatment is used for tumours with microsatellite instability high or mismatch repair deficiency but not all of these patients respond
Not all eligible patients respond to treatment with an immune checkpoint inhibitor
Pleural effusion was associated with worse patient characteristics, poorer survival and higher early death rates
Previously reported findings suggest that systemic antibiotic exposure may alter the efficacy of treatment with an immune checkpoint inhibitor by impacting the intestinal microbiota
Immunochemotherapy combinations have demonstrated improved efficacy over sole chemotherapy in diverse solid tumours
Life-threatening adverse events have been reported in some patients following immune checkpoint inhibitor treatment for cancer
Data from a propensity-matched survival analysis
Immune-related adverse events due to checkpoint inhibitor treatment can affect any organ and may be linked to ocular adverse events
Pembrolizumab led to significantly longer progression-free survival than chemotherapy in KEYNOTE-177 as first-line treatment for MSI-H/dMMR metastatic colorectal cancer
Evidence for efficacy is based on the results from the ARROW study
Clinical results support the probable benefit of MR-guided High Intensity Focused Ultrasound system for the ablation of painful osteoid osteoma
Pooled risk of cervical cancer increased in women living with HIV
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.
